Found 38 matching trials
Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC
PHASE2This is an exploratory, non-controlled, multi-cohort, phase II small-sample...
Location
Fudan University Shanghai Cancer Center
Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer
NAThis study aims to observe and explore the efficacy and safety of Anlotinib...
Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma
PHASE2Penpulimab plus chemotherapy with or without Anlotinib as first-line therap...
Location
Nanfang Hospital, Southern Medical University
A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer
PHASE2This is a single-arm, open-label, phase II clinical trial to evaluate the e...
Location
Peking Union Medical College Hospital
Penpulimab Combined With Anlotinib in Neoadjuvant Treatment of Resectable Non-small Cell Lung Cancer
PHASE4Neoadjuvant therapy with penpulimab combined with anlotinib;with surgery wi...
Location
Multiple Locations
Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy
PHASE2Anlotinib is a multi-target receptor tyrosine kinase inhibitor in domestic ...
Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma
PHASE2There is currently no standard first-line treatment for stage PPGL, and the...
Location
Cancer Center, Sun Yat-sen University
Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy
PHASE2This study is a two arm, randomized, prospective, multicenter study on the ...
Location
The First Affiliated Hospital of the Air Force Medical University
Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
PHASE2This is a prospective, open-label single-arm, exploratory, two-stage design...
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003
PHASE2A single-arm, open-label clinical trial, focus on the safety and efficacy o...
Location
Beijing Tiantan Hospital, Capital Medical University